CoChat

A Role for the Somatotropic Axis in Neural Development, Injury and Disease: Research Centre for Developmental Medicine and Biology, Faculty of Medical and Health Science, University of Auckland, Auckland, New Zealand

Scheepens, Arjan, Williams, Chris E., Breier, Bernhard Η., Guan, Jian, Gluckman, Peter D. · 2000 · Journal of Pediatric Endocrinology and Metabolism

The DOI matches its Crossref record.

Abstract

This review article discusses the roles of the somatotropic axis in the growth and development of the normal central nervous system (CNS) and during recovery from brain injury. Classically, the actions of pituitary-derived growth hormone (GH) have been reported to be primarily mediated via the induction of hepatic insulin-like growth factor-I (IGF-I). GH receptors (GHRs), however, have now been identified in many body tissues and shown to have both endocrine and local actions, some of which are IGF-I independent. Within the brain, GHRs are widely located across a range of cellular phenotypes, yet little is known regarding their function or endogenous ligand. It is now becoming accepted that GH, like IGF-I, is integrally involved in the growth and development of the normal CNS. Following brain injury, IGF-I mRNA is induced, primarily within reactive microglia. The resultant IGF-I protein appears to have a dual role, first as an endogenous neurotropic and anti-apoptotic agent acting directly on stressed cells, and second as a prohormone for generation of the N-terminal tripeptide of IGF-I, glycine-proline-glutamate (GPE), and the resulting des-N-(l-3)-IGF-I, both of which have specific neuroprotective properties. Our work on deciphering the upstream regulators of injury-induced IGF-I has revealed that a GH-like substance is strongly upregulated after brain injury and specifically associated with stressed neurons and glia. Subsequent to this finding, GH administered centrally 2 hours after a hypoxic-ischemic brain injury in juvenile rats was found to provide significant neuroprotection, interestingly, in a spatiotemporal pattern distinct from the neuroprotection offered by IGF-I. The implications of these findings in regard to the growth, development and injury response of the CNS are discussed.

Overview

Integrity signals

Registry

Crossref · 10.1515/jpem-2000-s623

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cited by

See all 82

Metadata

Authors
Scheepens, A., Williams, C. E., Breier, B. Η., Guan, J., & Gluckman, P. D.
Affiliations
University of Auckland (NZ)
Venue
Journal of Pediatric Endocrinology and Metabolism
Published
2000-12-01
Volume
13
Issue
s2
Pages
1483-1492
ISSN
  • 0334-018X (ISSN-L)
  • 2191-0251
OpenAlex
W2208861702
Cited by
82
References
0
Citations by year
2025: 1 · 2022: 4 · 2021: 4 · 2020: 1 · 2019: 1 · 2018: 1 · 2017: 4 · 2016: 4 · 2015: 2 · 2014: 6 · 2013: 5 · 2012: 6
FWCI
2.15
Type
journal article
Language
en
Open access
closed
Locations
  • Journal of Pediatric Endocrinology and Metabolism (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Growth Hormone and Insulin-like Growth Factors
  • Health Sciences › Medicine › Clinical Neurology › Traumatic Brain Injury and Neurovascular Disturbances
  • Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Neonatal and fetal brain pathology
Keywords
somatotropic axis, growth hormone, insulin-like growth factor I, growth hormone receptor, central nervous system development, brain injury, neuroprotection, hypoxic-ischemic brain injury, reactive microglia, neurotrophic factors, anti-apoptotic effects
MeSH terms
Aging, Brain, Brain Diseases, Brain Injuries, Central Nervous System, Humans, Receptors, Somatotropin, Somatomedins, Human Growth Hormone

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: A Role for the Somatotropic Axis in Neural Development, Injury and Disease: Research Centre for Developmental Medicine and Biology, Faculty of Medical and Health Science, University of Auckland, Auckland, New Zealand. https://app.cochat.ai/papers/10.1515/jpem-2000-s623
The paper
Scheepens, A., Williams, C. E., Breier, B. Η., Guan, J., & Gluckman, P. D. (2000). A Role for the Somatotropic Axis in Neural Development, Injury and Disease: Research Centre for Developmental Medicine and Biology, Faculty of Medical and Health Science, University of Auckland, Auckland, New Zealand. Journal of Pediatric Endocrinology and Metabolism. https://doi.org/10.1515/jpem-2000-s623

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.